MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 188 filers reported holding MEDIVATION INC in Q2 2013. The put-call ratio across all filers is 0.41 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,228,000 | -43.8% | 20,365 | -57.1% | 0.00% | -66.7% |
| Q1 2016 | $2,185,000 | +5.1% | 47,512 | +10.5% | 0.00% | +50.0% |
| Q4 2015 | $2,078,000 | +14.6% | 42,984 | +0.8% | 0.00% | 0.0% |
| Q3 2015 | $1,813,000 | -12.5% | 42,658 | +135.2% | 0.00% | 0.0% |
| Q2 2015 | $2,071,000 | +66.9% | 18,139 | +88.7% | 0.00% | +100.0% |
| Q1 2015 | $1,241,000 | +34.5% | 9,615 | +3.7% | 0.00% | 0.0% |
| Q4 2014 | $923,000 | -2.9% | 9,269 | -3.6% | 0.00% | 0.0% |
| Q3 2014 | $951,000 | +28.3% | 9,616 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $741,000 | +11.1% | 9,616 | -7.2% | 0.00% | 0.0% |
| Q1 2014 | $667,000 | +3.6% | 10,358 | +2.7% | 0.00% | 0.0% |
| Q4 2013 | $644,000 | +6.4% | 10,088 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $605,000 | -97.7% | 10,088 | -98.1% | 0.00% | -97.1% |
| Q2 2013 | $26,521,000 | – | 539,036 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |